ATE382373T1 - Radioaktiv markierte substrate - Google Patents

Radioaktiv markierte substrate

Info

Publication number
ATE382373T1
ATE382373T1 AT04714794T AT04714794T ATE382373T1 AT E382373 T1 ATE382373 T1 AT E382373T1 AT 04714794 T AT04714794 T AT 04714794T AT 04714794 T AT04714794 T AT 04714794T AT E382373 T1 ATE382373 T1 AT E382373T1
Authority
AT
Austria
Prior art keywords
radioactively labeled
labeled substrates
substrates
radioactively
radiolabelled
Prior art date
Application number
AT04714794T
Other languages
English (en)
Inventor
Antony David Gee
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE382373T1 publication Critical patent/ATE382373T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dry Shavers And Clippers (AREA)
  • Steroid Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
AT04714794T 2003-02-28 2004-02-26 Radioaktiv markierte substrate ATE382373T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0304681.0A GB0304681D0 (en) 2003-02-28 2003-02-28 Radiolabelled structures

Publications (1)

Publication Number Publication Date
ATE382373T1 true ATE382373T1 (de) 2008-01-15

Family

ID=9953904

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04714794T ATE382373T1 (de) 2003-02-28 2004-02-26 Radioaktiv markierte substrate

Country Status (8)

Country Link
US (1) US20070041899A1 (de)
EP (1) EP1608412B1 (de)
AT (1) ATE382373T1 (de)
CA (1) CA2516953A1 (de)
DE (1) DE602004011033T2 (de)
ES (1) ES2297390T3 (de)
GB (1) GB0304681D0 (de)
WO (1) WO2004075926A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7989630B2 (en) 2008-04-30 2011-08-02 National Institutes Of Health Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health Radiotracers for imaging P-glycoprotein function
CN110294756A (zh) * 2019-06-04 2019-10-01 广州市原子高科同位素医药有限公司 GluN2B亚基靶向型中枢神经系统正电子示踪剂及其制备

Also Published As

Publication number Publication date
DE602004011033T2 (de) 2009-01-02
US20070041899A1 (en) 2007-02-22
WO2004075926A1 (en) 2004-09-10
CA2516953A1 (en) 2004-09-10
EP1608412A1 (de) 2005-12-28
ES2297390T3 (es) 2008-05-01
EP1608412B1 (de) 2008-01-02
DE602004011033D1 (de) 2008-02-14
GB0304681D0 (en) 2003-04-02

Similar Documents

Publication Publication Date Title
ATE528989T1 (de) Kristalline feste rasagilin-base
CY1111518T1 (el) Tgf βητα 1 ειδικα αντισωματα
DK1487763T3 (da) Anvendelse af mikrofremstillede indretninger til radiosyntese
NO20065329L (no) Fremstilling av pregabalin og beslektede forbindelser.
NO20054485D0 (no) Fremgangsmate til bestemmelse av kontekstuell sammendragsinformasjon over dokumenter
LTC1608344I2 (lt) Per burną vartojamos kladribino kompozicijos
ATE473744T1 (de) Modifizierte pyrimidin-glucocorticoid-rezeptor- modulatoren
MA30153B1 (fr) Anticorps anti-ox40l et methodes correspondantes
AR061246A1 (es) Anticuerpos anti- dill4 y metodos que los usan
WO2010011407A3 (en) Methods of generating patterned soft substrates and uses thereof
NO20083397L (no) Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
ATE543921T1 (de) Ods-molybdän-silizium-bor-legierung
NO20080991L (no) Bazedoksifen acetat formuleringer
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
WO2008043543A3 (de) Nucleic acid beacons for fluorescent in-situ hybridisation and chip technology
NO20074277L (no) Kinnolinforbindelser og anvendelse derav som lever X reseptor modulatorer
ATE382373T1 (de) Radioaktiv markierte substrate
EA200601596A1 (ru) Улучшенный состав 6-меркаптопурина
TW200716130A (en) Purified form of tanaproget
ATE431164T1 (de) Röntgendichte cyanoacrylat-zusammensetzungen
ATE462574T1 (de) Abbildungskopfhalterung
WO2009023577A3 (en) Electrophotography device
FI20041388A0 (fi) Ainakin yhden vetyisotoopin käsittävien substraattien valmistus
ATE417816T1 (de) Anilinohexafluoroisopropanol verbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties